Core Scientific — Third Quarter 2026 Earnings Summary

Core Scientific reported third-quarter 2026 colocation revenue of $215.4 million, representing a nearly 60% sequential increase driven by the delivery of billing megawatts. The company achieved net income of $1.2 billion, a figure significantly boosted by a non-cash gain from the change in fair value of warrants, while Adjusted EBITDA more than tripled to $133.6 million with margins expanding to 57%. As of September 30, 2026, Core Scientific was billing for 485 MW of capacity, which translates to over $700 million in average annualized colocation revenue. The firm continues to advance construction across five campuses under its second colocation agreement while nearing full delivery of its first.